340B Drug Pricing Program
HRSA its long-awaited proposed 340B Drug Pricing Program “Mega Guidance,” in the form of a notice with a 60-day comment period. The notice includes the following key areas on which HRSA is either providing further clarification or seeking modifications: hospital eligibility; Group Purchasing Organization prohibition; patient definition; duplicate discounts; contract pharmacy; and hospital audits. The guidance also proposes enhanced program integrity requirements for pharmaceutical manufacturers participating in the 340B program.
Click here for AHA Bulletin on the new requirements.
ASHNHA sends out policy alerts to members as needed. Previous policy alerts are listed below.
Medicaid Presumptive Eligibility – October 31, 2013
EHR Incentive Program – October 21, 2013
Two Midnight Rule – October 8, 2013
2014 Final Medicare Payment Rule Highlights – September 6, 2013
Critical Access Hospital Revised Operations Manual – August 22, 2013
IRS Approved Delays and Changes to Play or Pay – July 12, 2013